Skip to content
Open Data Finder
Open Government Canada

Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.

Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10) · Open Data Finder